By David Arbanas StaffSource: Pharmacogenetics
Augusta-based Pharmacogenetics Development Co. creates new pharmaceutical compounds by using a process patented by Dr. Larry Hendry, an adjunct professor of physiology and endocrinology at the Medical College of Georgia. Here's how it works:
Dr. Hendry discovered "biologically active" chemical compounds (A) fit inside the "rungs" of the DNA double-helix ladder (B) to create a specific interaction (C).
He then mapped the compounds and the DNA's inside compartment (D) to create a "pharmacophore" (E) allowing researchers to know whether certain compounds will "fit" into the DNA and produce the desired effect on the body.
Compounds fitting inside the pharmacophore (F) will be active in a human body. Those that do not (G) will not interact with the gene and will not produce the desired effect.